Middle age: A critical turning point for brain health and cognition

Review emphasizes the significance of midlife for cognitive trajectories and brain health, advocating for research models that capture non-linear changes to better understand the unique processes occurring during this period.

JAPAC Drug Development: Safety & Regulatory Requirements

Dr. Jayawant Fuke, Senior Director of Lifecycle Safety, IQVI Hye Jin Choi, R. Ph., Sr. Director of Regulatory Affairs and Drug Development Solutions, IQVIA Asia

April 16, 2024

Trump 2.0 spells uncertainty for US healthcare, says analyst – Pharmaceutical Technology

Former Republican presidential candidate Robert F. Kennedy Jr. and President-elect Donald Trump after RFK suspended his own campaign to endorse Trump in August 2024. Credit:

November 13, 2024

Bristol Myers and 2seventy bio’s Abecma survival data raise questions ahead of FDA’s advisory committee meeting: #ASH23

SAN DIEGO — The FDA in November delayed its decision on whether to approve Bristol Myers Squibb and 2seventy bio’s CAR-T cell therapy for earlier

December 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.